More importantly, the impacts of SNHG17 down-regulation on the malignant behaviors of astrocytoma cells were counteracted by overexpressed ERLIN2 or inhibited miR-876-5p. Here, ERLIN2 is linked to astrocytoma (excluding glioblastoma).